Suchergebnisse - "Thompson, Jeffrey C"

PubPharm (41)

1

Red Blood Cells Function as Reservoirs of Tumor DNA

enthalten in: American journal of physiology. Lung cellular and molecular physiology | 2024

von Thompson, J. | Li, S. | Jose, J. | +6

2

Brief Report : Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

enthalten in: Clinical lung cancer | 2024

von Marmarelis, M. | Scholes, D. | McGrath, C. | +15

3

Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression

enthalten in: Clinical lung cancer | 2024

von Friedes, C. | Yegya-Raman, N. | Zhang, S. | +13

4

Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors

enthalten in: British journal of cancer | 2023

von Thompson, J. | Scholes, D. | Carpenter, E. | +1

5

Are radiomic signatures ready for incorporation in the clinical pipeline?

enthalten in: Translational lung cancer research | 2023

von Singh, A. | Roshkovan, L. | Thompson, J. | +2

CommentOn: Transl Lung Cancer Res. 2023 Jul 31;12(7):1575-1589. - PMID 37577298

6

Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer

enthalten in: JCO precision oncology | 2023

von Aggarwal, C. | Marmarelis, M. | Hwang, W. | +15

7

Could DNA Fragments Be the Key to Early Detection of Lung Cancer?

enthalten in: American journal of respiratory and critical care medicine | 2023

von Thompson, J. | Vachani, A.

CommentOn: Am J Respir Crit Care Med. 2023 May 1;207(9):1203-1213. - PMID 36346614

8

Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

enthalten in: JCO precision oncology | 2022

von Vega, D. | Nishimura, K. | Zariffa, N. | +32

ErratumIn: JCO Precis Oncol. 2023 Apr;7:e2300144. - PMID 37053538

9

Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expression

enthalten in: Clinical and translational medicine | 2022

von Sen, M. | Hausler, R. | Dulmage, K. | +12

10

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

enthalten in: Scientific reports | 2022

von Singh, A. | Horng, H. | Roshkovan, L. | +13

1
2
3
4
5
Nächster »
[5]